| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 120,016 | 112,505 | 145,103 | 181,366 | | Cost of Revenue | 90,763 | 87,239 | 103,134 | 79,066 | | | Gross Profit | 29,253 | 25,266 | 41,969 | 102,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,430 | 15,525 | 13,640 | 15,871 | | Non Recurring | (1,916) | 1,916 |
-
| 115,774 | | Others | 20,893 | 20,368 | 20,558 | 64,458 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,070) | (12,543) | 7,771 | (93,803) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,840) | 25,889 | 222 | 316 | | Earnings Before Interest And Taxes | (2,994) | 13,346 | 7,993 | (93,487) | | Interest Expense | 10,764 | 13,221 | 13,507 | 12,168 | | Income Before Tax | (13,758) | 125 | (5,514) | (105,655) | | Income Tax Expense | (4,108) | 215 | (2,909) | (35,271) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,715 | (90) | (2,605) | (70,384) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,650) | (90) | (2,605) | (70,384) | | Preferred Stock And Other Adjustments | (630) | (35) |
-
|
-
| | | Net Income Applicable To Common Shares | ($10,280) | ($125) | ($2,605) | ($70,384) |
|
0.11% Nasdaq 
0.01%
Income Statement
